531541 Stock Overview
Kobo Biotech Limited manufactures active pharmaceutical ingredients based on fermentation technology in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Kobo Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4.03 |
| 52 Week High | ₹6.01 |
| 52 Week Low | ₹2.04 |
| Beta | 0.95 |
| 1 Month Change | 6.05% |
| 3 Month Change | -10.64% |
| 1 Year Change | 56.81% |
| 3 Year Change | -38.19% |
| 5 Year Change | 18.53% |
| Change since IPO | -42.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531541 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.5% | 1.6% | 2.1% |
| 1Y | 56.8% | 57.6% | 45.9% |
Return vs Industry: 531541 matched the Indian Pharmaceuticals industry which returned 57.6% over the past year.
Return vs Market: 531541 exceeded the Indian Market which returned 45.9% over the past year.
Price Volatility
| 531541 volatility | |
|---|---|
| 531541 Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531541's share price has been volatile over the past 3 months.
Volatility Over Time: 531541's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | n/a | www.kobobiotech.com |
Kobo Biotech Limited manufactures active pharmaceutical ingredients based on fermentation technology in India. The company was formerly known as Avon Lifesciences Limited and changed its name to Kobo Biotech Limited in October 2020. Kobo Biotech Limited was incorporated in 1993 and is based in Mumbai, India.
Kobo Biotech Limited Fundamentals Summary
| 531541 fundamental statistics | |
|---|---|
| Market cap | ₹96.01m |
| Earnings (TTM) | -₹54.66m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.8x
P/E RatioIs 531541 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531541 income statement (TTM) | |
|---|---|
| Revenue | ₹0 |
| Cost of Revenue | ₹0 |
| Gross Profit | ₹0 |
| Other Expenses | ₹54.66m |
| Earnings | -₹54.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.29 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -107.1% |
How did 531541 perform over the long term?
See historical performance and comparison